Such discrepancy might be due to the difference between a totally stable genetic effect, operating since birth on one hand and, conversely the role exerted by serum adiponectin, whose levels are quite variable [48, 49], especially in heavily treated patients as are those with T2D [50, 51], and whose effect has been evaluated only for a few years. This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.